文献速递临床试验与 GCP

沉浸式虚拟现实技术对帕金森病抑郁患者心理康复的影响评估:一项随机对照试验的研究方案

Assessing the impact of immersive virtual reality technology on the psychological recovery of patients with Parkinson's disease depression: study protocol of a randomized controlled trial.
PubMed 文献 · Trials · 2024-10-25

本研究为单盲随机对照试验,拟招募74例帕金森病抑郁患者,随机分为VR组(n=37)接受每周3次、每次40分钟、共8周的VR辅助训练,非VR组(n=37)接受常规治疗。主要结局为汉密尔顿抑郁量表-24,次要结局包括36项简短健康调查问卷、神经炎症因子和功能磁共振成像,于干预前及干预后8周、3个月、6个月评估。

要点

  • VR组接受每周3次、每次40分钟、共8周的VR辅助训练,非VR组接受常规治疗。
  • 主要结局为汉密尔顿抑郁量表-24,次要结局包括生活质量问卷、神经炎症因子和功能磁共振成像。
  • 评估时间点为干预前及干预后8周、3个月、6个月。

核心结论

  • 本研究旨在评估沉浸式VR辅助训练对帕金森病抑郁患者的效应,可能为临床治疗提供一种改进方法,适用于临床决策和未来实践。

研究设计与样本

  • 单盲随机对照试验,拟招募74例帕金森病抑郁患者,随机分为VR组(n=37)和非VR组(n=37)。

关键数值与推荐

  • VR组接受VR辅助训练40分钟,每周3次,共8周;非VR组接受常规治疗。
  • 主要结局为汉密尔顿抑郁量表-24;次要结局包括36项简短健康调查问卷、神经炎症因子(脑源性神经营养因子、白细胞介素-6和C反应蛋白)和功能磁共振成像。
  • 结局评估于干预前及干预后8周、3个月、6个月进行。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: Depression in Parkinson's disease (DPD) has a high incidence rate among patients with Parkinson's disease (PD). It is a common nonmotor symptom of PD that seriously affects the quality of life of patients. Thus, improving DPD is important for improving the quality of life of patients. Psychotherapy for depression is limited for many reasons, and only a few patients are able to benefit from this therapy. Several studies have demonstrated that relaxation therapy, playing, and exercise therapy are effective treatments for depression. In recent years, virtual reality (VR) has rapidly developed as a form of rehabilitation due to its immersive characteristics and accessibility. It has also been applied in the psychological treatment of phobia and anxiety. However, no relevant research on the treatment of DPD has been conducted using VR. This study aims to assess the effects of immersive VR-assisted training on patients with DPD. METHODS: This single-blind randomized controlled trial will recruit 74 patients with DPD. The patients will then be randomly allocated into two groups. The patients in the VR group (n = 37) will receive VR-assisted training (40 min) three times a week for 8 weeks. The patients in the non-VR training group (n = 37) will receive treatment as usual. The outcome measures will be assessed before intervention, and after 8 weeks, 3 months, and 6 months of the intervention. The primary outcomes will include the Hamilton Depression Scale-24. The secondary outcomes will include the 36-Item Short-Form Health Survey questionnaire, neuroinflammation factors (brain-derived neurotrophic factor, interleukin-6, and C-reactive protein), and functional magnetic resonance imaging. DISCUSSION: The traditional treatment of depression has limited resources and requires a lot of time and energy. It is not suitable for patients with PD having mobility difficulties and residing in remote areas. VR can make up for limitations in traditional treatment methods. An advantage of VR is that it makes patients more invested in active participation. This study may provide an improved method for the clinical treatment of patients with DPD, which is suitable for clinical decision-making and future practice. TRIAL REGISTRATION: The study has been registered in the Chinese Clinical Trial Registry ChiCTR2200065843, November 16, 2022. https://www.chictr.org.cn/showproj.html?proj=174551 {2a and 2b}.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chen X, Chen L, Chen X, et al. Assessing the impact of immersive virtual reality technology on the psychological recovery of patients with Parkinson's disease depression: study protocol of a randomized controlled trial. Trials. 2024. PMID: 39456018. doi:10.1186/s13063-024-08552-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。